Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06601166 · ClinicalTrials.gov registry record · NA
CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin
A NA study, sponsored by DexCom.
- Active
- Registry status
- NA
- Development phase
- 283
- Enrollment target
NCT06601166 is a NA study that is active but no longer recruiting, run by DexCom. The registered enrollment target is 283 participants.
The verdict
NCT06601166, a NA study, is active but no longer recruiting, sponsored by DexCom.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 283 participants
- Enrollment target
Study Summary
This multi-center study is a 26-week randomized controlled trial (RCT) in which adults (≥18 years) with type 2 diabetes (T2D) not using insulin and managed in a primary-care setting will be randomly assigned 1:1 to either use of real-time continuous glucose monitoring (CGM) or routine care (RC) plus interval blinded CGM wear.
Interventions
- DEVICE CGM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 283 participants |
| Start Date | 2024-08-15 |
| Est. Completion | 2026-12-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06601166
The ClinicalTrials.gov registry entry for NCT06601166 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 283 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DexCom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CGM is the first listed.
NCT06601166 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06601166 about?
NCT06601166 is a clinical study titled "CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin". This multi-center study is a 26-week randomized controlled trial (RCT) in which adults (≥18 years) with type 2 diabetes (T2D) not using insulin and managed in a primary-care setting will be randomly assigned 1:1 to either use of real-time continuous glucose monitoring (CGM) or routine care (RC) plus...
What is the current status of trial NCT06601166?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 283 participants. The study started on 2024-08-15. Estimated completion is 2026-12-16.
What interventions are being tested in trial NCT06601166?
The interventions under investigation include: CGM (DEVICE).
Who is sponsoring clinical trial NCT06601166?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.